Keegan Matheson on Blue Jays, Baseball Memories, and More | SaltWire #writer #torontobluejays #mlbHYDERABAD - Indian drugmakers, which have the U.S. market as a key segment, will sustain their revenue improvement in fiscal 2025 due to drug shortages in the United States, Mumbai-based India Ratings and Research said on Monday.
There is an active shortage of 233 drugs across 22 therapeutic categories as of April, led mainly by discontinuing production of some drugs, rising demand and delays in shipments, it said, also citing data from the U.S. Food and Drug Administration. Reddy's reported a 29% jump in North America sales for the most recent quarter ended March 31, while Cipla saw an 11% jump in revenue from the region.India Ratings and Research said increasing regulatory costs led to many US-based generic pharma manufacturers halting the production of certain drugs.
Business Business Latest News, Business Business Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: BNNBloomberg - 🏆 83. / 50 Read more »